Clinical Innovations01.02.20
Clinical Innovations, a medical device company dedicated to labor and delivery and neonatal intensive care, has signed a definitive agreement to be acquired by Laborie Medical Technologies for an enterprise value of $525 million. The deal will support and strengthen Clinical Innovations' commitments to helping mothers and babies, product innovation, and serving markets around the world.
Laborie is a developer and manufacturer of medical diagnostics and devices in the pelvic health and gastroenterology market, owned by Patricia Industries, a part of Investor AB.
“This is a promising deal that will add scale to the overall business,” said Ken Reali, president and CEO of Clinical Innovations. “We share a similar vision for the continued growth of Clinical Innovations. The combination of Clinical Innovations and Laborie will have a positive impact for mothers, babies, and healthcare professionals.”
Clinical Innovations’ devices include the Kiwi Vacuum-Assisted Delivery System, babyLance Safety heel stick, ROM Plus Rupture of Membranes Test, ClearView Uterine Manipulator, Koala Intrauterine Pressure Catheter and ebb Complete Tamponade System. Clinical Innovations added SweetUms sucrose solution and the BoogieBaby oral and nasal suction device to its growing NICU product lineup earlier in December.
“Acquiring Clinical Innovations marks an important step in the evolution of our business and our continued investment in market-leading technologies for high-growth medical specialties that deliver clinical, access, and economic advantages,” said Michael Frazzette, president and CEO of Laborie Medical Technologies. “Clinical Innovations, which will form a stand-alone global business unit, immediately provides Laborie with a strong global presence in the L&D and NICU specialties. The company’s diversified, differentiated product portfolio truly makes a difference for clinicians and their patients.”
Laborie has agreed to acquire Clinical Innovations from funds managed by EQT. The deal is expected to close in early 2020.
Laborie is a developer and manufacturer of medical diagnostics and devices in the pelvic health and gastroenterology market, owned by Patricia Industries, a part of Investor AB.
“This is a promising deal that will add scale to the overall business,” said Ken Reali, president and CEO of Clinical Innovations. “We share a similar vision for the continued growth of Clinical Innovations. The combination of Clinical Innovations and Laborie will have a positive impact for mothers, babies, and healthcare professionals.”
Clinical Innovations’ devices include the Kiwi Vacuum-Assisted Delivery System, babyLance Safety heel stick, ROM Plus Rupture of Membranes Test, ClearView Uterine Manipulator, Koala Intrauterine Pressure Catheter and ebb Complete Tamponade System. Clinical Innovations added SweetUms sucrose solution and the BoogieBaby oral and nasal suction device to its growing NICU product lineup earlier in December.
“Acquiring Clinical Innovations marks an important step in the evolution of our business and our continued investment in market-leading technologies for high-growth medical specialties that deliver clinical, access, and economic advantages,” said Michael Frazzette, president and CEO of Laborie Medical Technologies. “Clinical Innovations, which will form a stand-alone global business unit, immediately provides Laborie with a strong global presence in the L&D and NICU specialties. The company’s diversified, differentiated product portfolio truly makes a difference for clinicians and their patients.”
Laborie has agreed to acquire Clinical Innovations from funds managed by EQT. The deal is expected to close in early 2020.